PLSMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Pulsenmore Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026
$1.78−0.09 (-4.81%)
Close on Oct 19, 2026
Share price
−$4.14 (−69.93%)since Jan 23, 2026
Weekly closes, adjusted for splits, on a log scale. Drag across the chart to measure a change.
Pulsenmore Ltd. grew revenue 314.3% to 40.02M ILS over fiscal 2025. Free cash flow was -33.01M ILS.
Revenue
40.02M ILS
+314.3% vs. a year earlier
Free cash flow
-33.01M ILS
FY2025
EPS, diluted
2.46 ILS
-57.3% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over fiscal 2025, balances at Dec 31, 2025
Valuation
- Market cap
- –
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- 40.02M ILS
- EPS, diluted
- 2.46 ILS
- Free cash flow
- -33.01M ILS
Valuation needs the share price. It fills in once daily prices are connected and converted from ILS.
Four years at a glance
Fiscal years 2022 to 2025, ILS
Revenue
40.02M ILS+314.3% YoY
Gross profit
33.68M ILS+841.6% YoY
EPS, diluted
2.46 ILS-57.3% YoY
Free cash flow
-33.01M ILS
Reported period